Results of cisplatin, adriamycin and etoposide chemotherapy in patients with recurrent and metastatic endometrial cancer

European Journal of Gynaecological Oncology

Volumn 25, Issue 3, 2004, Pages 379-380

  Bilgin, T ^a,b   Ozan, H ^a   Kara, H Filiz ^a  

^a ULUDAG UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Adriamycin; Chemotherapy; Cisplatin; Endometrial cancer; Etoposide

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; MEGESTROL ACETATE;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIGESTIVE SYSTEM ULCER; DRUG EFFICACY; ENDOMETRIUM CANCER; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; HUMAN; MELENA; METASTASIS; NEUTROPENIA; RECURRENT CANCER; STOMATITIS; SURVIVAL TIME; THROMBOCYTOPENIA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DOXORUBICIN; ENDOMETRIAL NEOPLASMS; ETOPOSIDE; FEMALE; HUMANS; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TURKEY;

EID: 2342525248     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Thigpen T., Vance R.B., Khansur T.: "The platinum compounds and paclitaxel in the management carcinomas of the endometrium and uterine cervix". Semin. Oncol., 1995, 22 (suppl.), 67S.
2. Elit L., Hirte H.: "Novel strategies for systemic treatment of endometrial cancer". Expert Opin. Investig. Drugs, 2000, 9, 2831.
3. Pierga J.Y., Dieras V., Beuzeboc P., Dorval T., Palangie T., Jouve M. et al.: "Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma". Gynecol. Oncol., 1997, 66, 246.
4. Cornelison T.L., Baker T.R., Piver M.S., Driscoll D.L.: "Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma". Gynecol. Oncol., 1995, 59, 243.
5. Lissoni A., Gabriele A., Gorga G., Tumolo S., Landoni F., Mangioni C., Sessa C.: "Cisplatin, epirubicin and paclitaxel containing chemotherapy in uterine adenocarcinoma". Ann. Oncol., 1997, 8, 969.
6. Gebbia V., Testa A., Borsellino N., Ferrera P., Tirrito M., Palmeri S.: "Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: a new highly active chemotherapeutic regimen". Ann. Oncol., 2001, 12, 767.
7. Gadducci A., Romanini A., Cosio S., Fanucchi A., Tanganelli L., Ciam B., Genazzani A.R.: "Combination of cisplatin, epirubicin, and cyclophosphamide (PEC regimen) in advanced or recurrent endometrial cancer: a retrospective clinical study". Anticancer Res., 1999, 19, 2253.
8. Fung M.F., Krepart G.V., Lotocki R.J., Heywood M.: "Treatment of recurrent and metastatic adenocarcinoma of the endometrium with cisplatin, doxorubicin, cyclophosphamide and medroxyprogesterone acetate". Obstet. Gynecol., 1991, 78, 1033.